JOHNSON & JOHNSON (JNJ) Options Risk Score
Real-time risk analysis for JNJ options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full JNJ options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan JNJ Now — Free →
Is it risky to sell options on JOHNSON & JOHNSON (JNJ) right now?
JOHNSON & JOHNSON (JNJ) currently scores 27 out of 100 for options catalyst risk (LOW) over a 4-week expiry window. What pushes it there: an upcoming earnings report, 2 recent news items, 6 active legal filings, 1 recent SEC event and 46 clinical-trial catalysts, all landing inside the 4-week window. Below 45 is LOW: JNJ's calendar looks clear across this window. Unscheduled news can still move any stock, so a low score is the absence of a known event, not the absence of risk.
JNJ shows an IV Rank of 72 — implied volatility is near the top of its own one-year range, so JNJ options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 26%. Read IV Rank alongside the catalyst score: it says how expensive JNJ options are, while the score says whether that price is justified by a scheduled event.
The 2026-10-13 earnings report sits inside a standard monthly expiry for JNJ, so implied volatility should stay bid into the date and drop sharply once it passes.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer